Cargando…
H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs
Platinum-based anticancer agents have revolutionized oncological treatments globally. However, their therapeutic efficacy is often accompanied by systemic toxicity. Carboplatin, recognized for its relatively lower toxicity profile than cisplatin, still presents off-target toxicities, including dose-...
Autores principales: | Yamashita, Atsushi, Park, Seung Hun, Zeng, Lingxue, Stiles, Wesley R., Ahn, Sung, Bao, Kai, Kim, Jonghan, Kang, Homan, Choi, Hak Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607179/ https://www.ncbi.nlm.nih.gov/pubmed/37895146 http://dx.doi.org/10.3390/ijms242015466 |
Ejemplares similares
-
Injectable Thermosensitive Hydrogels for a Sustained Release of Iron Nanochelators
por: Park, Seung Hun, et al.
Publicado: (2022) -
Editorial: New Approaches in Toxicity Testing of Nanotherapeutics
por: Kalangi, Suresh K., et al.
Publicado: (2022) -
External and Internal Stimuli-Responsive Metallic Nanotherapeutics for Enhanced Anticancer Therapy
por: Mohapatra, Adityanarayan, et al.
Publicado: (2021) -
Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
por: Parodi, Alessandro, et al.
Publicado: (2022) -
Design of Safe Nanotherapeutics for the Excretion
of Excess Systemic Toxic Iron
por: Abbina, Srinivas, et al.
Publicado: (2019)